ReviewJournal of aging research2013
Alzheimer's disease clinical and research update for health care practitioners.
Review in Journal of aging research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Cognition enhancing effect of rosemary (Rosmarinus officinalis L.) in lab animal studies: a systematic review and meta-analysis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022Pooled it
- Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease.CNS neuroscience & therapeutics · 2014Pooled it
- Advances in the treatment of Alzheimer's disease.Frontiers in pharmacology · 2026Review
- Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential.Molecular and cellular biochemistry · 2025Review
- Deciphering Neuroprotective Effect ofCurrent drug targets · 2024Review
- New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.Molecular and cellular biochemistry · 2023Review
- Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities.International journal of molecular sciences · 2021Review
- [Network pharmacology-based study of the therapeutic mechanism of resveratrol for Alzheimer's disease].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021Article
- Western diet aggravates neuronal insult in post-traumatic brain injury: Proposed pathways for interplay.EBioMedicine · 2020Review
- Comparing patient and informant ratings of depressive symptoms in various stages of Alzheimer's disease.Neuropsychology · 2020Article
- A multiparametric organ toxicity predictor for drug discovery.Toxicology mechanisms and methods · 2020Article
- Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology.Molecular neurobiology · 2019Review
- Age-related epigenetic changes in hippocampal subregions of four animal models of Alzheimer's disease.Molecular and cellular neurosciences · 2018Article
- Detecting Memory Impairment in Deaf People: A New Test of Verbal Learning and Memory in British Sign Language.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2016Article
- Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.Neuromolecular medicine · 2016Article
- Interactions of the histamine and hypocretin systems in CNS disorders.Nature reviews. Neurology · 2015Review
- Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.Current psychiatry reports · 2014Article
- Etiology and pathogenesis of late-onset Alzheimer's disease.Current allergy and asthma reports · 2014Review
- Electroacupuncture at PC6 or ST36 Influences the Effect of Tacrine on the Motility of Esophagus.Evidence-based complementary and alternative medicine : eCAM · 2014Article
- Vitamin D and neurocognitive function.Clinical interventions in aging · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Of the approximately 6.8 million Americans who have been diagnosed with dementia, over 5 million have been diagnosed with Alzheimer's Disease (AD). Due to the rise in the aging population, these figures are expected to double by 2050. The following paper provides an up-to-date review of clinical issues and relevant research. Research related to the methods of the earliest possible detection of AD is ongoing. Health care professionals should play a critical role in differentially diagnosing AD patients, as well as supporting their families. Novel interventions, including medications, natural supplements, and behavioral techniques, are constantly appearing in the literature. It is necessary for the health practitioner to remain current, regarding AD, as such information will facilitate better care for patients and their families.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.